Short answer
Nutex Health Inc. (NUTX) filed an 8-K current report with the SEC on November 5, 2026 reporting Item 2.02 (Results of Operations and Financial Condition), Item EX-99.1 (Exhibit EX-99.1). Q3 2026 results announced for the quarter ended September 30, 2026.
Nutex Health Inc. 8-K event analysis
AI summary of each reported item and its exhibits
Item 2.02 · Results of Operations and Financial Condition
- Q3 2026 results announced for the quarter ended September 30, 2026
- Investor-relevant financial and operating details contained in Exhibit 99.1 press release
Item EX-99.1 · Exhibit EX-99.1
- Q3 revenue fell 18.7% to $217.6 million, while net income declined to $40.2 million from $55.4 million
- Nine-month revenue decreased 10.9% to $644.9 million, despite net income rising to $152.9 million from $59.0 million
- Nine-month earnings benefited from a $52.3 million non-cash contract-services estimate change, adding $25.0 million to net income
- Hospital visits grew 18.1% year over year in Q3, but same-hospital revenue declined 20.1%, highlighting reimbursement and collection timing pressure
- Cash reached $249.9 million, operating cash flow totaled $188.1 million, and long-term debt was $34.2 million at September 30, 2026
Generated from the filing text and exhibits; verify against the original. What 8-K item codes mean
Other Nutex Health Inc. 8-K filings
Get the next NUTX 8-K as it lands
Follow NUTX for push alerts, or ask the research agent what this filing means.